Clinical trial
A Prospective Translational Tissue Collection Study in Early and Advanced Gastric and Oesophageal Cancers to Enable Further Disease Characterisation and the Development of Potential Predictive and Prognostic Biomarkers
NCT06702384 is registered in ClinicalTrials.gov with Royal Marsden NHS Foundation Trust as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Translational Tissue Collection Study in Early and Advanced Gastric and Oesophageal Cancers to Enable Further Disease Characterisation and the Development of Potential Predictive and Prognostic Biomarkers
- Lead sponsor
- Royal Marsden NHS Foundation Trust
- Phase
- Observational
- Overall status
- Withdrawn
- Start date
- August 31, 2025
- Completion date
- May 31, 2030
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
adenocarcinoma - gej, adenocarcinoma esophagus, adenocarcinoma of the stomach, squamous cell car. - esophagus